BiotechTube
Home/Abpro/Miles Suk
MS

Miles Suk

CEO, Chairman

Abpro

Therapeutic Areas

Oncology

Abpro Pipeline

DrugIndicationPhase
ABP-102 / CT-P72HER2-positive cancersPreclinical

Leadership Team at Abpro

RM
Robert Markelewicz, MD
Chief Medical Officer
View full Abpro profile